The Henri A. Termeer Tribute Committee
Committee Co-Chairs:
Robert Coughlin, CEO, MassBIO
John Maraganore, Ph.D., CEO, Alnylam
Committee Members:
Belinda and Adriana Termeer
Lisa Adler
Joseph Aoun, Ph.D., President, Northeastern University
Joshua Boger, Ph.D., Founder, Vertex Pharmaceuticals
Zoltan Csimma, Chair, International Institute of New England (IINE)
George Daley, M.D., Ph.D., Dean of the Faculty, Harvard Medical School
Daniel de Boer, CEO, ProQR Therapeutics N.V.
Deborah Dunsire, M.D., CEO, Xtuit
John Fish, Chairman and CEO, Suffolk Construction
Keith Flaherty, M.D., Director, Termeer Center for Targeted Therapies, MGH
Jim Geraghty, Chair, Idera and Juniper Pharmaceuticals
James Greenwood, CEO, BIO
Tuan Ha-Ngoc, Executive Chairman, KEW
Daniel Haber, M.D., Ph.D., Director, MGH Cancer Center
John Hawkins, Vice Chair, Odgers Berndtson
Bill Kane, SVP, BioMed Realty
Laurie Keating, SVP, General Counsel, Alnylam and BOD member of MassBIO
Jeff Leerink, Chair and CEO, Leerink Partners
Christine Lindenboom, VP, Corporate Communications, Alnylam
Gail Maderis, CEO, Antiva
Geoffrey McDonough, M.D., CEO Generation Bio
David Meeker, M.D., CEO, KSQ Therapeutics
Yannis Miaoulis, Ph.D., President, Museum of Science
Mike Minogue, Chair and CEO, Abiomed
Mikko Nissinen, Artistic Director, Boston Ballet
Stelios Papadopoulos, Ph.D., Chair of the Board, Biogen
Bo Piela, Head of Communications, Sanofi Genzyme
Victoria Reggie Kennedy, Board President and Co-founder, Edward M. Kennedy Institute for the United States Senate
Rafael Reif, Ph.D., President, MIT
Bill Sibold, Head of Sanofi Genzyme
Peter Slavin, M.D., President, Mass General Hospital
David Torchiana, M.D., CEO, Partners HealthCare System
Stephane van Rooijen, M.D., CEO Dynacure (France)
Chris Viehbacher, CEO, Gurnet Capital
Alan Walts, Ph.D., Partner, Advent Life Sciences
Christoph Westphal, M.D., Ph.D., Co-Founding Partner, Longwood Fund
Andrey Zarur, Ph.D., CEO, Greenlight Bio